Clinical Trials Browser

Phase 2 × Fenretinide × Head & Neck × Clear all

NCT00006471 2018-11-01

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00004161 2013-04-12

Fenretinide in Treating Patients With Leukoplakia of the Mouth

Phase 2 Completed

Head and Neck Neoplasms, Mouth Neoplasms

NCT00003223 2012-07-24

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Phase 2 Terminated

Head and Neck Neoplasms, Mouth Neoplasms